X-108696340-C-T
Position:
Variant summary
Our verdict is Pathogenic. Variant got 12 ACMG points: 12P and 0B. PVS1_ModeratePM2PP5_Very_Strong
The NM_033380.3(COL4A5):c.5038C>T(p.Arg1680*) variant causes a stop gained change. The variant allele was found at a frequency of 0.000000912 in 1,096,247 control chromosomes in the GnomAD database, with no homozygous occurrence. There are no hemizygote samples in GnomAD. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★).
Frequency
Genomes: not found (cov: 22)
Exomes 𝑓: 9.1e-7 ( 0 hom. 0 hem. )
Consequence
COL4A5
NM_033380.3 stop_gained
NM_033380.3 stop_gained
Scores
3
1
1
Clinical Significance
Conservation
PhyloP100: 4.01
Genes affected
COL4A5 (HGNC:2207): (collagen type IV alpha 5 chain) This gene encodes one of the six subunits of type IV collagen, the major structural component of basement membranes. Mutations in this gene are associated with X-linked Alport syndrome, also known as hereditary nephritis. Like the other members of the type IV collagen gene family, this gene is organized in a head-to-head conformation with another type IV collagen gene so that each gene pair shares a common promoter. Alternatively spliced transcript variants have been identified for this gene. [provided by RefSeq, Aug 2010]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Pathogenic. Variant got 12 ACMG points.
PVS1
Loss of function variant, product does not undergo nonsense mediated mRNA decay. Variant is located in the 3'-most exon, not predicted to undergo nonsense mediated mRNA decay. Fraction of 0.00749 CDS is truncated, and there are 0 pathogenic variants in the truncated region.
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant X-108696340-C-T is Pathogenic according to our data. Variant chrX-108696340-C-T is described in ClinVar as [Pathogenic]. Clinvar id is 24785.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chrX-108696340-C-T is described in Lovd as [Pathogenic]. Variant chrX-108696340-C-T is described in Lovd as [Pathogenic]. Variant chrX-108696340-C-T is described in Lovd as [Likely_pathogenic].
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
COL4A5 | NM_033380.3 | c.5038C>T | p.Arg1680* | stop_gained | 53/53 | ENST00000328300.11 | NP_203699.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
COL4A5 | ENST00000328300.11 | c.5038C>T | p.Arg1680* | stop_gained | 53/53 | 1 | NM_033380.3 | ENSP00000331902.7 |
Frequencies
GnomAD3 genomes Cov.: 22
GnomAD3 genomes
Cov.:
22
GnomAD4 exome AF: 9.12e-7 AC: 1AN: 1096247Hom.: 0 Cov.: 28 AF XY: 0.00 AC XY: 0AN XY: 361745
GnomAD4 exome
AF:
AC:
1
AN:
1096247
Hom.:
Cov.:
28
AF XY:
AC XY:
0
AN XY:
361745
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome Cov.: 22
GnomAD4 genome
Cov.:
22
ClinVar
Significance: Pathogenic
Submissions summary: Pathogenic:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Pathogenic:3
Pathogenic, criteria provided, single submitter | research | Gharavi Laboratory, Columbia University | Sep 16, 2018 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Jan 23, 2023 | Nonsense variant predicted to result in protein truncation, as the last 12 amino acids are lost, and other loss-of-function variants have been reported downstream in HGMD; Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 12105244, 30577881, 20378821, 30586318) - |
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Feb 08, 2023 | This sequence change creates a premature translational stop signal (p.Arg1674*) in the COL4A5 gene. While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 12 amino acid(s) of the COL4A5 protein. This variant is not present in population databases (gnomAD no frequency). This premature translational stop signal has been observed in individuals with Alport syndrome (PMID: 12105244, 20378821, 30577881). This variant is also known as p.Arg1680*. ClinVar contains an entry for this variant (Variation ID: 24785). This variant disrupts a region of the COL4A5 protein in which other variant(s) (p.Arg1677*) have been determined to be pathogenic (PMID: 10094548, 12796257, 19728970, 19965530). This suggests that this is a clinically significant region of the protein, and that variants that disrupt it are likely to be disease-causing. For these reasons, this variant has been classified as Pathogenic. - |
X-linked Alport syndrome Pathogenic:2
Pathogenic, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Feb 09, 2022 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Institute of Human Genetics Munich, Klinikum Rechts Der Isar, TU München | Dec 06, 2018 | - - |
Alport syndrome Pathogenic:1
Pathogenic, no assertion criteria provided | research | Department of Traditional Chinese Medicine, Fujian Provincial Hospital | - | In a male patient with Alport syndrome, we found the mutant c.5038C>T (p.Arg1680Ter), which results in a shortened protein that causes illness. His renal pathology showed negative type IV collagen staining for alpha 3 and alpha 5, focal foamy cells in the renal interstitium, and stratified alterations in the basement membrane on electron microscopy, all of which were thought to be signs of renal damage associated with X-linked Alport syndrome. Furthermore, numerous investigations have established the pathogenicity of this mutant location (PMID: 10094548, 12796257, 19728970, 19965530). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Pathogenic
D
BayesDel_noAF
Pathogenic
CADD
Pathogenic
DANN
Uncertain
FATHMM_MKL
Pathogenic
D
Vest4
GERP RS
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at